Additionally, EGFR was amplified in the MCR of 7p11.2, whereas CADM2, which has been identified as a tumor suppressor gene in prostate cancer [23,24], was deleted in the MCR of 3p12.1. This evidence concerns the gene EGFR and prostate cancer.